Genome-wide analysis of the parkinsonism-dementia complex of Guam.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Neurology

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.61.12.1889PMID 15596609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997–2000

  2002cited by this paper
• ALS and PDC of Guam: Forty-year follow-up

  2002influential reference
• TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.

  2001influential reference
• Molecular Genetic Characterisation of Frontotemporal Dementia on Chromosome 3

  1999cited by this paper
• Neurodegenerative diseases of Guam: Analysis of TAU

  1999cited by this paper
• Low frequency of α‐synuclein mutations in familial Parkinson's disease

  1998cited by this paper
• Genetic classification of primary neurodegenerative disease.

  1998cited by this paper
• Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.

  1998cited by this paper
• Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam

  1997cited by this paper
• Destiny's landfall : a history of Guam

  1996cited by this paper
• Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.

  1996cited by this paper
• A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci.

  1995cited by this paper
• Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: Descriptive epidemiology, secular trends, and birth cohort effects on incidence, 1950-1989

  1994cited by this paper
• The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam.

  1994cited by this paper
• Guam ALS-PDC: possible causes.

  1993cited by this paper
• An unusual retinal pigment epitheliopathy endemic to the island of Guam.

  1993cited by this paper
• Sequencing of exons 16 and 17 of the β-amyloid precursor protein gene reveals the β-amyloid sequence to be normal in cases of the parkinson dementia complex of guam

  1993cited by this paper
• SEQUENCING OF EXON-16 AND EXON-17 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE REVEALS THE BETA-AMYLOID SEQUENCE TO BE NORMAL IN CASES OF THE PARKINSON DEMENTIA COMPLEX OF GUAM

  1993cited by this paper
• Geographic patterns of parkinsonism-dementia complex on Guam. 1956 through 1985.

  1990cited by this paper
• Estimating the power of a proposed linkage study for a complex genetic trait.

  1989cited by this paper
• A retinopathy on Guam with high prevalence in Lytico-Bodig.

  1989cited by this paper
• Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin.

  1987cited by this paper
• Disappearance of high‐incidence amyotrophic lateral sclerosis and parkinsonism‐dementia on Guam

  1985cited by this paper
• Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

  1985cited by this paper
• Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam.

  1984cited by this paper
• Calcium and vitamin D metabolism in guamanian chamorros with amyotrophic lateral sclerosis and parkinsonism–dementia

  1984cited by this paper
• Parkinsonism‐dementia in a Filipino migrant

  1982cited by this paper
• Amyotrophic lateral sclerosis among chamorro migrants from guam

  1980cited by this paper
• Neurofibrillary degeneration on Guam: frequency in Chamorros and non Chamorros with no known neurological disease.

  1979cited by this paper
• Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology.

  1975cited by this paper
• Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology

  1972cited by this paper
• Amyotrophic lateral sclerosis and parkinsonism dementia in a migrant population from Guam

  1969cited by this paper
• Amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam: further genetic investigations.

  1969cited by this paper
• Amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam. IV. Familial and genetic investigations.

  1967cited by this paper
• Parkinsonism-dementia complex, en endemic disease on the island of Guam. Clinical, pathological, genetic and epidemiological features.

  1961cited by this paper
• Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features.

  1961cited by this paper
• Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features.

  1961cited by this paper
• Amyotrophic lateral sclerosis among Guamanians in California.

  1957cited by this paper
• Neurologic diseases on the island of Guam.

  1954cited by this paper
• Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution and special reference to the Mariana Islands, including clinical and pathologic observations.

  1954cited by this paper
• Neurologic diseases on the island of Guam.

  1954cited by this paper
• Epidemiologic Investigations of Amyotrophic Lateral Sclerosis

  1954cited by this paper
• Endemic amyotrophic lateral sclerosis on Guam; epidemiological data; a preliminary report.

  1953cited by this paper
• Amyotrophic lateral sclerosis on Guam.

  1952cited by this paper
• AMYOTROPHIC LATERAL SCLEROSIS ON GUAM: A CLINICAL STUDY AND REVIEW OF THE LITERATURE

  1952cited by this paper

• Development of Patient-Derived Neuroprogenitor Cells (hNPCs), Neurons and Astrocytes to Explore the Etiology of Guam Parkinsonism-Dementia Complex (PDC)

  2025cites this paper
• Linking Environmental Genotoxins to Neurodegenerative Diseases Through Transcriptional Mutagenesis

  2024cites this paper
• Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research.

  2024cites this paper
• Introducing the Role of Genotoxicity in Neurodegenerative Diseases and Neuropsychiatric Disorders

  2024cites this paper
• Chronic BMAA exposure combined with TDP-43 mutation elicits motor neuron dysfunction phenotypes in mice.

  2023cites this paper
• Tau Filaments from Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) adopt the CTE Fold

  2023cites this paper
• Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions

  2023cites this paper
• Asociación Parkinson-demencia y esclerosis lateral amiotrófica (complejo Guam). Reto diagnóstico, paciente mexicano

  2023cites this paper
• Brain health for all on World Brain Day 2022.

  2022cites this paper
• Amyotrophic lateral sclerosis from genotoxins alone?

  2022cites this paper
• Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.

  2021cites this paper
• The Lessons of ALS‐PDC – Environmental Factors in ALS Etiology

  2021cites this paper
• Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.

  2020cites this paper
• Tau at the interface between neurodegeneration and neuroinflammation

  2020cites this paper
• Validation of a novel progressive rat model of Parkinson’s disease using in vivo positron emission tomography, behavioural assessments, and in vitro autoradiography

  2019cites this paper
• A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans

  2017cites this paper
• Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.

  2016cites this paper
• Environmental Neurotoxins Linked to a Prototypical Neurodegenerative Disease

  2015cites this paper
• Manipulating microglia in Alzheimer's disease

  2015cites this paper
• Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72

  2015cites this paper
• Cellular transport and secretion of the cyanobacterial neurotoxin BMAA into milk and egg : Implications for developmental neurotoxicity

  2015cites this paper
• Development of an analytical procedure for quantifying the underivatized neurotoxin β-N-methylamino-l-alanine in brain tissues

  2014cites this paper
• Neurogenetics: A Guide for Clinicians

  2012cites this paper
• Spatial distribution and secular trends in the epidemiology of Alzheimer's disease.

  2012cites this paper
• Guam dementia syndrome revisited in 2011.

  2011cites this paper
• The ALS/PDC syndrome of Guam: potential biomarkers for an enigmatic disorder.

  2011cites this paper
• Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders

  2011cites this paper
• Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four

  2010cites this paper
• Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients.

  2010cites this paper
• Predictors of Breast and Cervical Cancer Screening among Chamorro Women in Southern California

  2010cites this paper
• Review Article Neuropathology of non-Alzheimer degenerative disorders

  2010cites this paper
• Environmental neurotoxin‐induced progressive model of parkinsonism in rats

  2010cites this paper
• Neuropathology of non-Alzheimer degenerative disorders.

  2010cites this paper
• Development and application of a comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-alanine in human tissue.

  2010cites this paper
• TRPM7 is not associated with amyotrophic lateral sclerosis‐parkinsonism dementia complex in the Kii peninsula of Japan

  2009influential citation
• Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

  2009cites this paper
• Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.

  2009cites this paper
• Contributions of isolated Pacific populations to understanding neurodegenerative diseases.

  2009cites this paper
• Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond

  2009cites this paper
• Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease

  2008cites this paper
• Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/PDC)

  2008influential citation
• Mutation analyses in amyotrophic lateral sclerosis/parkinsonism–dementia complex of the Kii peninsula, Japan

  2008cites this paper
• Sporadický "guamský parkinsonský komplex" nebo koincidence více neurodegenerativních onemocnění?

  2008cites this paper
• Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.

  2007cites this paper
• Genetic Characterisation of Neurodegenerative disorders

  2007cites this paper
• Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

  2007cites this paper
• Chapter 14 Familial amyotrophic lateral sclerosis.

  2007cites this paper
• Drug discovery: selecting the optimal approach.

  2006cites this paper
• Strategies to optimize the validity of disease models in the drug discovery process.

  2006cites this paper
• Clinical, pathological and biochemical diversity in progressive supranuclear palsy

  2006cites this paper
• Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex

  2006cites this paper
• Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau

  2006cites this paper
• Sporadic amyotrophic lateral sclerosis as an infectious disease: a possible role of cyanobacteria?

  2006cites this paper
• The genetics of neurodegenerative diseases

  2006cites this paper
• Superoxide dismutase 1 and amyotrophic lateral sclerosis

  2005cites this paper
• Parkinsonism–dementia complex of Guam

  2005cites this paper
• Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.

  2005cites this paper
• John C

  2004cites this paper
• List of Papers

  1992cites this paper
• Acta Universitatis Upsaliensis Uppsala 2015

  year unknowncites this paper